Company
Jellatech
Regenerate the human body.
- Status
- Operatingas of 2026-09-23
- Business model
- B2B
- Customers
- aesthetics, wound healing, orthopedics, cell therapy and nutrition companies
- Legal name
- Jellatech, Inc.
Claim, correct or request removal
Record updated 28 September 2026
About
Our vision is to regenerate the human body and extend human healthspan. We do it by producing the proteins the body is built from, at scale, on spec. Human collagen type I is the first building block.
Funding snapshot
- Total raised
- $6.5MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $3.5M2023-08-23
Funding rounds
- Round, 2023
- $3.5M2023-08-23, SEC form D sold, 8 investors
- Round, 2023
- $165K2023-01-25, SEC form D sold, 4 investors
- Round, 2022
- $75K2022-07-13, SEC form D sold, 1 investor
- Round, 2021
- $926K2021-11-17, SEC form D sold, 5 investors
- Round, 2021
- $100K2021-10-30, SEC form D sold, 1 investor
- Round, 2021
- $725K2021-02-10, SEC form D sold, 2 investors
- Round, 2020
- $975K2020-11-30, SEC form D sold, 4 investors
Products
- Other
- Human collagen type I
Loading relationship preview